FDA draft guidance on AI/ML in Healthcare

FDA’s Draft Guidance and Webinar on AI/ML in Healthcare

The FDA has recently released a new draft guidance on “Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence/Machine Learning (AI/ML)-Enabled Device Software Functions”. This draft guidance proposes a novel and flexible regulatory approach for AI/ML-based medical devices, inviting public comments until July 3, 2023. A significant tool that can help in…

Read more

Let’s Elevate Your Regulatory Strategy

Work with a team that combines startup agility with deep regulatory knowledge across the UK, Australia, and New Zealand. From technical documentation to training and in-country representation — we’re here to help you succeed.